Historic and Hopeful Day for Patients living with Lupus – FDA Advisory Committee’s Recommendation to Approve Benlysta for Lupus

 

The U.S. FDA Arthritis Advisory Committee voted 13 to 2 to recommend approvalof the treatment developed by Human Genome Sciences (HGS) and GlaxoSmithKline

Tuesday, November 16, 2010

The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations are pleased with the U.S. Food and Drug Administration (FDA) Advisory Committee’s vote to recommend approval of Benlysta® for active systemic lupus erythematosus (SLE), offering patients new found hope for the first approved treatment option in more than 50 years.

The U.S. FDA Arthritis Advisory Committee voted 13 to 2 to recommend approval of the treatment developed by Human Genome Sciences (HGS) and GlaxoSmithKline. The FDA will take the Advisory Committee’s vote into consideration as it reviews Benlysta for approval. A decision by the FDA is expected to be announced by December 9, 2010.

“The panel’s recommendation may signal the historic breakthrough that lupus patients have long awaited,” said Margaret G. Dowd, president of the LRI, an organization uniquely dedicated to funding innovative approaches to lupus research. “This positive vote reinforces our community’s resolve to increase the pace of scientific discovery and clinical development in lupus, made possible by the active participation of lupus patients in clinical trials.”

“The results of both of Benlysta’s phase III trials, BLISS-52 and BLISS-76, show that it reduces SLE disease activity, has a favorable safety profile and allows lupus patients to reduce their use of current treatment options that can cause serious adverse effects,” said Benjamin Schwartz, M.D., Ph.D., a professor of clinical medicine at Washington University School of Medicine in St. Louis and a member of the LRI Scientific Advisory Board.“Benlysta would be a welcome addition to the limited number of treatments available for people with lupus.”

“It’s exhausting to be on such a tedious schedule of medicines which cause so many side effects,” said lupus patient, Sabrina Nixon, “If approved, Benlysta will hopefully decrease the number of medications patients like me will need to stay alive.”

Lupus is a perilous and chronic autoimmune disease that impacts an estimated 1.5 million Americans, primarily young women in their childbearing years. In lupus, the immune system attacks the body’s own tissues and vital organs, making the illness a leading cause of premature cardiovascular disease, heart attack, stroke, and kidney disease among young women. Finding the cause, the cure and new treatments for lupus is a complex and challenging process.

source: http://lupusresearchinstitute.org Founded in 2000, the Lupus Research Institute is the nation’s only nonprofit organization solely dedicated to driving novel research in lupus. The LRI funds innovative and creative research to discover new scientific solutions for the disease.

Some more information on the topic:

Benlysta Diagram

 

___________________________________________________________

 

From Christine:

How do I feel about the news about BenLysta? I feel hope for the first time in my life with lupus. I am aware that this is nota cure, but a new treatment. But the fact that it is a new treatment for the first time in over 50 years excites me. The thought that it can change my quality of life, change how I can care for my family, and care for myself… is almost too much to imagine. I need to take pills 4-5 times a day. Over the course of the day that equals 18 pills. I don’t even want to do the math of what that is over a lifetime! If Benlysta can help lower or take away any of these toxic medications, I will be happy.  If it doesn’t work for me, but does for others in the Lupus community, I am happy.  I see this as the first HUGE step in scientists, government, pharmaceutical companies and doctors taking Lupus seriously and starting to focus their time and energy not just on Lupus but on all autoimmune diseases. This could be the start of something great. Hey, Lupus is in the news.. that’s always a plus. Whenever a product comes out, you know that down the road their will be “competitive” companies trying to do better, or cheaper versions of this drug, or new drugs for lupus.  Today’s hearing broke down years of the same old treatments, with the same nasty side effects. I hope my daughter knows a totally different life with lupus then I know now.  I hope she gets to know her  mother even better, since maybe I will feel even better. Maybe just maybe, this drug will be approved, the people living with lupus can receive it, and lives can start changing. A girl can dream can’t she?

Over all I am happy, I am hopeful, and I am excited for what the future holds and I thank the researchers and scientists behind Benlysta for making this drug a priority.

 

 

©2019butyoudontlooksick.com
  • Teri Jackson

    The easy part is done now we have to get the price down and get insurance companies to stop over questioning the drug. Mine approved the first 3 loading doses then my Doc took blood all came back nearly normal so the insurance co decided they were experimenting on me. 10K per dose? Really?

  • Steph

    I actually had this discussion with my Rheumatologist this morning at my appointment. She walked into the room already high-fiving me over the victory yesterday. She has repeatedly told me that I will be the first person in her practice that she will put on Benlysta once it is fully approved. Westomoon has a valid point as she said to me that it’s not as effective with the African American patients, but it seems to be mostly positive results with Caucasions. *Have I mentioned I love this woman?* She is so open minded about treatments and truly listens when I talk…but I digress….

    Like you said Christine, I am just thankful that Lupus is in the public eye now and that efforts are being made to find a better treatment if not a cure. My Rheumie DID tell me today that there are newer, most likely BETTER drugs being formulated behind Benlysta, but this is the jumping off point. We have to get Benlysta approved and in the market for these other “better” ones to gain momentum.

    It’s a slow motion, but it’s at least a forward motion.

    Someday, I can only hope that this technology progresses and wipes Lupus and ALL autoimmune diseases from the face of the Earth.

  • westomoon

    I agree that it was pretty amazing to have lupus in the news, especially with a ray of hope attached. But I’d recommend reading the NY Times article on this drug before throwing your other meds out the window. It’s at http://www.nytimes.com/2010/11/17/health/17drug.html?_r=1&ref=business .

    There are oddities about the drug’s success — it benefits only 1 in 11 patients treated, it appears not to benefit African-Americans at all, it seems not to work as well on Americans and Canadians as on Europeans, and it was not tested on patients with the most severe symptoms.

    Still, it made me breathe a little easier too to know that if things start running amok in my body, there’s another option now — if I’m the one in 11 that benefits from this drug, of course.

  • Kristy Howard

    That is such great news. I am so excited! I have so much trouble with side affects and adverse reactions to meds. It give me alot of hope for my Lupus and everyone else who suffers from it.

  • That is super! I’m so excited for you and others with Lupus. It is always great to see a silver lining of hope to hold tight to when you are not well.

    Many blessings!

  • Jen Martin

    Prayers that this will help many!

  • clara elliott

    awsome… we all need hope……

    living with lupus